CBD-Intel

Regulatory alerts roundup

CBD-Intel regulatory news in brief, 17th-23rd April

Written by || 23rd April 2021 || Regulatory alerts roundup | Regulation and Legislation | Africa Asia Canada China Colorado Europe Florida Germany Idaho Latvia Lesotho Malawi Malta Netherlands North America North Dakota Poland Spain United Kingdom United States Washington Wisconsin

This week's regulatory news in brief includes updates from Germany, Latvia Malta, Netherlands, Poland, Spain, UK, Canada, US, China, Lesotho and Malawi ...

Restricted content. Do you want to read more?

Read related content from CBD-Intel

Regulatory report: financial services for CBD companies in the US
Details of China’s proposed ban on CBD in cosmetics still unclear
Regulatory report: Netherlands

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions